Ensuring Advancements, Fortifying Presence
Welcome to Kopran, where excellence in Formulation Research and Development takes center stage. As a technology-driven pharmaceutical leader, we are dedicated to pushing the boundaries of innovation in the industry. Our Formulation Development and Analytical Development departments, supported by cutting-edge laboratories and top-tier technical experts, make Kopran a powerhouse of pharmaceutical advancement.
With our state-of-the-art research centre, we lead the way to pioneer a progressive production model. Our R&D teams focus on the development of APIs and Custom Synthesis, we are excellent in multi-step chemical synthesis with diversified reaction types including the use of delicate chiral molecules and hazardous chemistries. We adhere highest standards of Legal and Regulatory requirements during development of scalable and cost-effective APIs.
Emphasizing continuous improvement in processes, quality, and the creation of novel products, Kopran stands at the forefront of technological evolution. Our fully-equipped laboratories facilitate comprehensive physical, chemical, and micro-biological testing, ensuring the highest standards in pharmaceutical development.
Discover Kopran’s state-of-the-art research facility dedicated to the development of generic finished dosage forms. With a focus on oral and parenteral medications for both regulated and emerging markets, our center excels in developing, scaling up, and commercializing various dosage forms, including tablets, capsules, Dry powder suspension and injectable drug delivery systems.
Supported by an analytical team proficient in developing complex in-vitro analytical methods, our formulation team works tirelessly to innovate and enhance existing products.
A dedicated team of over 50 scientists, alongside a committed Project Management Team, propels our Formulation and Analytical research towards success.
WE ARE AN R&D-DRIVEN COMPANY, Run by a highly qualified team of professionals, custom synthesis is performed in accordance with the new generation API requirements. With world class capabilities and technological insight, we add value to the customer by providing High Quality APIs & Customised Services at affordable pricing.
With our state-of-the-art research centre, we lead the way to pioneer a progressive production model. Our R&D teams focus on the development of APIs and Custom Synthesis, we are excellent in multi-step chemical synthesis with diversified reaction types including the use of delicate chiral molecules and hazardous chemistries. We adhere highest standards of Legal and Regulatory requirements during development of scalable and cost-effective APIs.
Life cycle management – Continuous focus on Process Improvements to excel on quality, Productivity and sustainability on our existing products.
Interesting Facts
1st company to receive Drugs Controller General of India (DCGI) approval for launch of Biapenem in India and commercialise the same
1st company to launch Biapenem in Russia
Filed process patent applications for Nitroxoline in India, the EU and China
Received process patent for Nitroxoline in India
Registered Nitroxoline in Germany
R&D Process
Kopran is led and driven by its expertise in Research and Development, visible through its success in creating niche and differentiated products portfolio.
Our Global Formulation R&D center at Khopoli drives high value product delivery via latest technology platforms.
Kopran R&D is actively engaged in the development of a wide range of dosage forms with special emphasis on novel drug delivery systems for solid orals (modified release tablets and capsules) and dry syrup for both Regulated and Emerging markets.
Our product selection for development is mainly focussed on niche products characterized by complex formulations across diverse therapeutic segments.
With over 40 plus scientists, the R&D team offers solutions across the entire product development value chain including strategic sourcing, IP management, formulation development, analytical method development and validation, technology transfer, bio-equivalence,, packaging development and global regulatory submissions.
Expert team of Technology transfer for quicker Site Variations in critical markets where the lead time for variation approval is longer.
Our R&D facility is equipped with state-of-art infrastructure that capable to handle approx. 30 new product development project at any point in time.
Expertise in Analytical Method development/Validation/Verification and method transfer activities.
Technical expertise in Manufacturing and Packing process validation, scale up, technology transfer and trouble shooting.
Working constantly on process and yield improvements of existing products to make them more competitive
Ensuring smooth production of various organic intermediates and active pharmaceutical ingredients leveraging our robust R&D team
Supporting our team of committed scientists with a state-of-the-art research centre, as well as a pilot plant, in order to meet the ever evolving and challenging client expectations
Protecting the environment in terms of pollution and energy reduction